Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R La Montagne

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Journal of Infectious Diseases|February 10, 2004
Severe acute respiratory syndrome: developing a research responseJohn R La Montagne, Lone Simonsen, Robert J Taylor, et al.
The Journal of Infectious Diseases|August 10, 2005
A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusceptionAlbert Z Kapikian, Lone Simonsen, Timo Vesikari, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Journal of Infectious Diseases|February 10, 2004
Severe acute respiratory syndrome: developing a research responseJohn R La Montagne, Lone Simonsen, Robert J Taylor, et al.
The Journal of Infectious Diseases|August 10, 2005
A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusceptionAlbert Z Kapikian, Lone Simonsen, Timo Vesikari, et al.
Pageof 1